CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −15,211 | $28.75 | $437K | 32,546 |
| 2025-06-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −15,211 | 791 | ||
| 2025-06-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +27,594 | $13.35 | $368K | 37,009 |
| 2025-06-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −27,594 | $29.02 | $801K | 9,415 |
| 2025-06-03 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −27,594 | 0 | ||
| 2025-06-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +18,299 | $18.00 | $329K | 45,308 |
| 2025-06-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −18,299 | $28.80 | $527K | 27,009 |
| 2025-06-03 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −18,299 | 0 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,397 | 137,199 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,397 | 2,738,816 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +50,394 | 50,394 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +50,394 | 50,394 | ||
| 2025-05-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +62,116 | $1.59 | $99K | 158,790 |
| 2025-05-28 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −62,116 | $27.33 | $1.7M | 96,674 |
| 2025-05-28 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −62,116 | 0 | ||
| 2025-05-27 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +19,317 | $1.59 | $31K | 115,991 |
| 2025-05-27 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −19,317 | $27.01 | $522K | 96,674 |
| 2025-05-27 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −19,317 | 62,116 | ||
| 2025-05-23 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +4,837 | $1.59 | $8K | 101,511 |
| 2025-05-23 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −4,837 | $27.00 | $131K | 96,674 |
Page 32 of 74 · 1,467 trades